Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Photoreceptors and Visual Pathways01:22

Photoreceptors and Visual Pathways

6.1K
At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category,...
6.1K
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

1.6K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.6K
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

1.0K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Enhanced EBNA2-dependent activity in EBV-transformed B cells from patients with multiple sclerosis.

medRxiv : the preprint server for health sciences·2026
Same author

Reply to: A Lethal Progressive Neuroinflammation Disguised as MOGAD Revealing a Final Diagnosis of Griscelli Syndrome: Regarding: MOGAD is the Most Common Cause of Isolated Optic Neuritis in Children.

Annals of clinical and translational neurology·2026
Same author

Adaptation of the Transition Readiness Assessment Questionnaire for Pediatric-Onset Multiple Sclerosis: Protocol for a User-Centered Design Approach.

JMIR research protocols·2026
Same author

New-onset refractory status epilepticus/febrile infection-related epilepsy syndrome centers of excellence: A framework for coordinated care, research, and improved outcomes.

Epilepsia·2026
Same author

MOGAD Is the Most Common Cause of Isolated Optic Neuritis in Children.

Annals of clinical and translational neurology·2026
Same author

Erratum: Phase I Trial of GD2.CART Cells Augmented With Constitutive Interleukin-7 Receptor for Treatment of High-Grade Pediatric CNS Tumors.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

Related Experiment Video

Updated: Jul 23, 2025

Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4
09:29

Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4

Published on: August 21, 2017

11.5K

Pediatric Neuromyelitis Optica Spectrum Disorder.

Kelsey Poisson1, Karen Moeller2, Kristen S Fisher3

  • 1Department of Neurology, University of Alabama at Birmingham, Birmingham, AL; Department of Pediatrics, Division of Pediatric Neurology, Children's of Alabama, Birmingham, AL.

Seminars in Pediatric Neurology
|July 14, 2023
PubMed
Summary

Neuromyelitis Optica Spectrum Disorder (NMOSD) is a rare pediatric demyelinating disease. Early diagnosis and treatment are crucial as over half of children with AQP4-IgG seropositive NMOSD face permanent disability.

More Related Videos

Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients
12:23

Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients

Published on: April 14, 2014

14.1K
Optical Coherence Tomography: Imaging Mouse Retinal Ganglion Cells In Vivo
08:17

Optical Coherence Tomography: Imaging Mouse Retinal Ganglion Cells In Vivo

Published on: September 22, 2017

19.4K

Related Experiment Videos

Last Updated: Jul 23, 2025

Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4
09:29

Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4

Published on: August 21, 2017

11.5K
Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients
12:23

Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients

Published on: April 14, 2014

14.1K
Optical Coherence Tomography: Imaging Mouse Retinal Ganglion Cells In Vivo
08:17

Optical Coherence Tomography: Imaging Mouse Retinal Ganglion Cells In Vivo

Published on: September 22, 2017

19.4K

Area of Science:

  • Neurology
  • Immunology
  • Pediatrics

Background:

  • Neuromyelitis Optica Spectrum Disorder (NMOSD) is a severe demyelinating autoimmune disease.
  • It is characterized by astrocytopathy, often involving antibodies against the aquaporin-4 (AQP4) water channel.
  • Pediatric NMOSD is rare, representing 3-5% of cases, and is more common in individuals of Black or East Asian ancestry.

Purpose of the Study:

  • To summarize the key aspects of pediatric Neuromyelitis Optica Spectrum Disorder.
  • To highlight the clinical presentation, diagnostic markers, and treatment options for NMOSD in children.
  • To underscore the long-term disability risks associated with pediatric NMOSD.

Main Methods:

  • Review of existing literature on pediatric NMOSD.
  • Analysis of core clinical syndromes and diagnostic criteria.
  • Evaluation of current and emerging therapeutic strategies.

Main Results:

  • Pediatric NMOSD presents with syndromes including optic neuritis, myelitis, and brainstem/diencephalic involvement.
  • Aquaporin-4 IgG (AQP4-IgG) seropositivity is a key diagnostic marker.
  • First-line treatments include rituximab, azathioprine, and mycophenolate mofetil.

Conclusions:

  • Pediatric NMOSD carries a high risk of permanent visual and motor disability, affecting over 50% of AQP4-IgG seropositive children.
  • While novel adult therapies are emerging, pediatric treatment focuses on established immunosuppressants.
  • Further research into pediatric-specific NMOSD treatments is warranted.